NEW YORK (GenomeWeb News) - Clinical Data's PGxHealth division has inked a sub-license agreement with Australia’s Victorian Clinical Genetics Services for a test that is aimed at diagnosing a deadly heart disorder.
Under the non-exclusive agreement, VCGS, a subsidiary of the Murdoch Children's Research Institute, will use the PGxHealth diagnostic to test for familial long QT syndrome in Australia and in New Zealand.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.